Trauma scores and neuron-specific enolase, cytokine and c-reactive protein levels as predictors of mortality in patients with blunt head trauma

Journal of International Medical Research

Volumn 38, Issue 5, 2010, Pages 1708-1720

  Sogut, O ^a   Guloglu, C ^b   Orak, M ^b   Sayhan, M B ^c   Gokdemir, M T ^d   Ustundag, M ^b   Akkus, Z ^b  

^a HARRAN UNIVERSITY   (Turkey)

^b DICLE UNIVERSITY   (Turkey)

^c Edirne Public Hospital   (Turkey)

^d Sanliurfa Research and Training Hospital ^*  (Turkey)

Author keywords

Blunt head trauma; C reactive prote; C reative protein; Cytokines; Glasgow coma scae; Neuron specific; Revised trauma scorewords: be

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; NEURON SPECIFIC ENOLASE; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; CHILD; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE SEVERITY; FEMALE; GLASGOW COMA SCALE; HEAD INJURY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL; RATING SCALE; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY;

EID: 78449291037     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001003800516     Document Type: Article

References (40)

1. Chamoun RB, Robertson CS, Gopinath SP: Outcome in patients with blunt head trauma and a Glasgow Coma Scale score of 3 at presentation. J Neurosurg 2009; 111: 683-687.
2. Dash PK, Zhao J, Hergenroeder G, et al: Biomarkers for the diagnosis, prognosis, and evaluation of treatment efficacy for traumatic brain injury. Neurotherapeutics 2010; 7: 100-114.
3. Gabbe BJ, Cameron PA, Finch CF: The status of the Glasgow Coma Scale. Emerg Med (Fremantle) 2003; 15: 353-360.
4. Gabbe BJ, Cameron PA, Finch CF: Is the revised trauma score still useful? ANZ J Surg 2003; 73: 944-948.
5. Steel DM, Whitehead AS: The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 1994; 15: 81-88.
6. Streetz KL, Wüstefeld T, Klein C, et al: Mediators of inflammation and acute phase response in the liver. Cell Mol Biol (Noisy-le-grand) 2001; 47: 661-673.
7. Day IN, Thompson RJ: Levels of immunoreactive aldolase C, creatine kinase- BB, neuronal and non-neuronal enolase, and 14-3-3 protein in circulating human blood cells. Clin Chim Acta 1984; 136: 219-228.
8. Anastasiades KD, Mullins RE, Conn RB: Neuron-specific enolase. Assessment by ELISA in patients with small cell carcinoma of the lung. Am J Clin Pathol 1987; 87: 245-249.
9. Faist E, Schinkel C, Zimmer S: Update on the mechanisms of immune suppression of injury and immune modulation. World J Surg 1996; 20: 454-459.
10. Rutland-Brown W, Langlois JA, Thomas KE, et al: Incidence of traumatic brain injury in the United States, 2003. J Head Trauma Rehabil 2006; 21: 544-548.
11. Langlois JA, Rutland-Brown W, Wald MM: The epidemiology and impact of traumatic brain injury: a brief overview. J Head Trauma Rehabil 2006; 21: 375-378.
12. Peden M, McGee K, Sharma G: The Injury Chart Book: a Graphical Overview of the Global Burden of Injuries. Geneva: World Health Organization, 2002.
13. Tagliaferri F, Compagnone C, Korsic M, et al: A systematic review of brain injury epidemiology in Europe. Acta Neurochir (Wien) 2006; 148: 255-268.
14. Guerrero JL, Thurman DJ, Sniezek JE: Emergency department visits associated with traumatic brain injury: United States, 1995 - 1996. Brain Inj 2000; 14: 181-186.
15. Kraus JF, McArthur DL: Epidemiologic aspects of brain injury. Neurol Clin 1996; 14: 435-450.
16. Centers for Disease Control and Prevention (CDC): Traumatic brain injury - Colorado, Missouri, Oklahoma, and Utah, 1990 - 1993. MMWR Morb Mortal Wkly Rep 1997; 46: 8-11.
17. Türedi S, Hasanbasoglu A, Gunduz A, et al: Clinical decision instruments for CT scan in minor head trauma. J Emerg Med 2008; 34: 253-259.
18. Simon B, Letourneau P, Vitorino E, et al: Pediatric minor head trauma: indications for computed tomographic scanning revisited. J Trauma 2001; 51: 231-237.
19. Schunk JE, Rodgerson JD, Woodward GA: The utility of head computed tomographic scanning in pediatric patients with normal neurologic examination in the emergency department. Pediatr Emerg Care 1996; 12: 160-165.
20. Teasdale G, Jennett B: Assessment of coma and impaired consciousness. A practical scale. Lancet 1974; 304: 81-84.
21. Luk SS, Jacobs L, Ciraulo DL, et al: Outcome assessment of physiologic and clinical predictors of survival in patients after traumatic injury with a trauma score less than 5. J Trauma 1999; 46: 122-128.
22. Ritchie PD, Cameron PA, Ugoni AM, et al: A study of the functional outcome and mortality in elderly patients with head injuries. J Clin Neurosci 2000; 7: 301-304.
23. Meredith W, Rutledge R, Hansen AR, et al: Field triage of trauma patients based upon the ability to follow commands: a study in 29,573 injured patients. J Trauma 1995; 38: 129-135.
24. Kuhls DA, Malone DL, McCarter RJ, et al: Predictors of mortality in adult trauma patients: the physiologic trauma score is equivalent to the Trauma and Injury Severity Score. J Am Coll Surg 2002; 194: 695-704.
25. Kavalci C, Pekdemir M, Durukan P, et al: The value of serum tau protein for the diagnosis of intracranial injury in minor head trauma. Am J Emerg Med 2007; 25: 391-395.
26. Liliang PC, Liang CL, Weng HC, et al: Tau proteins in serum predict outcome after severe traumatic brain injury. J Surg Res 2010; 160: 302-307.
27. Bone RC: Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. Crit Care Med 1996; 24: 163-172.
28. Pullicino EA, Carli F, Poole S, et al: The relationship between the circulating concentrations of interleukin 6 (IL-6), tumor necrosis factor (TNF) and the acute phase response to elective surgery and accidental injury. Lymphokine Res 1990; 9: 231-238.
29. Shohami E, Novikov M, Bass R, et al: Closed head injury triggers early production of TNF α and IL-6 by brain tissue. J Cereb Blood Flow Metab 1994; 14: 615-619.
30. Dinarello CA: The biological properties of interleukin-1. Eur Cytokine Netw 1994; 5: 517-531.
31. Goss JR, Styren SD, Miller PD, et al: Hypothermia attenuates the normal increase in interleukin 1 RNA and nerve growth factor following traumatic brain injury in the rat. J Neurotrauma 1995; 12: 159-167.
32. Norris JG, Benveniste EN: Interleukin-6 production by astrocytes: induction by the neurotransmitter norepinephrine. J Neuroimmunol 1993; 45: 137-145.
33. Casey LC, Balk RA, Bone RC: Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 1993; 119: 771-778.
34. McClain C, Cohen D, Phillips R, et al: Increased plasma and ventricular fluid interleukin-6 levels in patients with head injury. J Lab Clin Med 1991; 118: 225-231.
35. Partrick DA, Moore FA, Moore EE, et al: The inflammatory profile of interleukin-6, interleukin-8, and soluble intercellular adhesion molecule-1 in postinjury multiple organ failure. Am J Surg 1996; 172: 425-431.
36. Kossmann T, Stahel PF, Lenzlinger PM, et al: Interleukin-8 released into the cerebrospinal fluid after brain injury is associated with blood- brain barrier dysfunction and nerve growth factor production. J Cereb Blood Flow Metab 1997; 17: 280-289.
37. Is M, Coskun A, Sanus GZ, et al: High-sensitivity C-reactive protein levels in cerebrospinal fluid and serum in severe head injury: relationship to tumor necrosis factor-alpha and interleukin-6. J Clin Neurosci 2007; 14: 1163-1171.
38. Kövesdi E, Lückl J, Bukovics P, et al: Update on protein biomarkers in traumatic brain injury with emphasis on clinical use in adults and pediatrics. Acta Neurochir (Wien) 2010; 152: 1-17.
39. Royds JA, Timperley WR, Taylor CB: Levels of enolase and other enzymes in the cerebrospinal fluid as indices of pathological change. J Neurol Neurosurg Psychiatry 1981; 44: 1129-1135.
40. Li N, Shen JK, Zhao WG, et al: S-100B and neuron specific enolase in outcome prediction of severe head injury. Chin J Traumatol 2004; 7: 156-158.